论文部分内容阅读
目的通过对国产与进口噻托溴铵治疗慢性阻塞性肺疾病(COPD)费效比与临床疗效观察以对广大COPD患者做出正确的用药指导。方法选取自2011年以来入该院治疗的COPD患者241例,其中:以进口噻托溴铵(思力华)维持治疗组121例。以国产噻托溴铵(天睛速乐)维持治疗组120例。15d为1个疗程,12个疗程以后观察患者病情体征变化。结果 2组患者治疗效果并无明显差异。结论国产与进口噻托溴铵治疗COPD疾病效果在无明显差异的情况下选取国产药品会大大降低COPD患者的经济负担。
Objective To compare the cost-effectiveness ratio and clinical efficacy of domestic and imported tiotropium in the treatment of chronic obstructive pulmonary disease (COPD) to guide the correct medication for COPD patients. METHODS: A total of 241 COPD patients admitted to the hospital since 2011 were enrolled. Among them, 121 were treated with tiotropium (SI). To domestic tiotropium bromide (Tianle rapid) maintenance treatment group of 120 cases. 15d for a course of treatment, after 12 courses of observation of patients with signs of change. Results There was no significant difference between the two groups in the treatment effect. Conclusion Domestic and imported tiotropium treatment of COPD disease in the absence of significant differences in the selection of domestic drugs will greatly reduce the economic burden of COPD patients.